Hjem › Myotonisk dystrofi › New York
Myotonisk dystrofi kliniske forsøg i New York
8 studier for Myotonisk dystrofi søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
- University of Rochester Medical Center, Rochester
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07486934A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
- Columbia University Medical Center - Neurological Institute, 710 W. 168th, 2nd floor, suite 204 - Site Number : 8400003, New York
RekruttererFase 1/2
Alder 10 til 55 · Alle køn · Opdateret 21. sep. 2026 · NCT06844214DMCRN-02-001: Assessing Pediatric Endpoints in DM1
- University of Rochester Medical Center, Rochester
RekruttererObservationsstudie
59 Months · Alle køn · Opdateret 10. jun. 2026 · NCT05224778Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- University of Rochester, Rochester
RekruttererObservationsstudie
Alder 18 til 70 · Alle køn · Opdateret 10. jun. 2026 · NCT03981575Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
- University of Rochester, Rochester
RekruttererObservationsstudie
Alder 0 til 17 · Alle køn · Opdateret 5. jun. 2026 · NCT07630389Remote Assessments and Genetic Determinants of Myotonic Dystrophy
- University of Rochester, Rochester
RekruttererObservationsstudie
Alder 18 til 88 · Alle køn · Opdateret 1. apr. 2026 · NCT07505342Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
- University of Rochester Medical Center, Department of Neurology, Rochester
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 15. okt. 2025 · NCT00082108Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
- University of Rochester - Medical Center, Rochester
RekruttererFase 2/3
Alder 6 til 45 · Alle køn · Opdateret 28. maj 2025 · NCT05004129Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.